Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparison of Prostate Cancer-related Quality of Life in Sexually Active Men With Favourable Intermediate-risk Localised Prostate Cancer Treated With Total Prostatectomy or Focal HIFU
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche
Summary
The goal of this trial is to assess the impact of focal HIFU therapy on quality of life in patients with favourable intermediate-risk localised prostate cancer. The main question it aims to answer is: What is the prostate cancer-related quality of life in patients with favourable intermediate-risk localised cancer treated by total prostatectomy or focal HIFU ? Researchers will compare patients with favourable intermediate-risk localised cancer treated by total prostatectomy to patients with favourable intermediate-risk localised cancer treated by focal HIFU to see their quality of life. Participants will answer EPIC-CP questionnaire 6 months, 12 months and 24 months after treatment
Key Details
Gender
MALE
Age Range
40 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
102
Start Date
2025-10-01
Completion Date
2028-12-31
Last Updated
2025-09-29
Healthy Volunteers
No
Conditions
Interventions
Total prostatectomy
Total prostatectomy is a surgical procedure performed to treat prostate cancer.
Focal HIFU
Focal HIFU treatment is an innovative technique that consists of destroying prostate tumour cells using high-intensity ultrasound focused exclusively on the affected area of the gland.
Locations (1)
Clinique La Croix du Sud
Quint-Fonsegrives, France